If you cannot see this email, please click here
 

Dear Colleague,

With the full weight of President Obama behind regulatory pathway developments, a raft of biological drugs coming off patent imminently, and intensifying governmental pressure to reduce healthcare costs – the time has never been more ripe for FOBs market entry!

But with the huge commercial opportunities, come enormous risks and challenges! This unique strategically focused FOBs conference goes beyond the hype and provides you with the down-to-earth practical information you need to enable you to:

  • Clarify the FOBs business case
  • Devise your commercial FOBs strategy
  • Ensure a high impact entry into the US FOBs market

Benefit from the analyses, insights and practical advice of 18 industry leading speakers, all in just two intensive days!

To view the complete agenda and speaker line up CLICK HERE.

Don’t delay! Booking is easy, either go online at: www.informex-fobs.com, email us at: conferences@ubm.com or call us on:
609-759-4707.

I look forward to welcoming you and your colleagues in September.

In the meantime please give me a call if you have any questions at all.

Kind Regards,

Jennifer Jessup
Event Director, Informex Conferences

PS: Group Discounts available! Call us on 609-759-4707 and save up to 20% on your group booking TODAY!

 
For More Information:

Online: www.informex-fobs.com 

Customer services can be contacted on:

Phone: +1-609-759-4707
Fax: +1-516-467-8270

 

Save up to $200 by booking before July 17, 2009

 

Hear from 18 market leaders including:

Brian Harvey
VP Regulatory Policy
Sanofi-Aventis

Christopher Slavinsky
Senior Corporate Counsel
Pfizer

Christine Mundkur
President and CEO, Head Commercial Operations North America
Sandoz US

Fadel Hamed
Head of Operational Excellence
Genentech

Emily Shacter
Chief Lab. Biochem, Div. Therapeutic Proteins
FDA

Raghav Chari
VP, Corporate Development – NCE/Specialty
Dr Reddy's

Marcy Macdonald
Director Global
Regulatory Affairs
Hospira

Diane Edquist Dorman
VP for Public Policy
National Organization for Rare Disorders (NORD)

Barbara Ryan
Managing Director
Deutsche Bank Securities

 

Produced by:

 
 
 

Media Partners:

Organised by: UBM Information Ltd, Ludgate House, 245 Blackfriars Road, London, SE1 9UY
UBM Information Ltd. Place of registration: England and Wales. Registered number: Company number 370721. Registered address: Ludgate House 245 Blackfriars Road London SE1 9UY
If you would prefer not to receive conference emails from InformExUSA please click here

 

[*track.css*] [*track.hidden*]